[February 23, 2017] |
|
Bioverativ to Present at the Cowen and Company 37th Annual Health Care Conference
Bioverativ
Inc. (NASDAQ: BIVV) announced today that it will present at the
Cowen and Company 37th Annual Health Care Conference. The event will be
webcast live on Monday, March 6, 2017 at 1:20 p.m. EST. To access the
live webcast, please visit Bioverativ's Investors page at investors.bioverativ.com.
An archived verson of the webcast will be available following the
presentation.
About Bioverativ Bioverativ (NASDAQ: BIVV) is a global
biotechnology company dedicated to transforming the lives of people with
hemophilia and other rare blood disorders through world-class research,
development and commercialization of innovative therapies. Launched in
2017 following separation from Biogen Inc., Bioverativ builds upon a
strong heritage of scientific innovation and is committed to actively
working with the blood disorders community. The company's mission is to
create progress for patients where they need it most and its hemophilia
therapies when launched represented the first major advancements in
hemophilia treatment in more than two decades. For more information,
visit www.bioverativ.com
or follow @bioverativ
on Twitter (News - Alert).
View source version on businesswire.com: http://www.businesswire.com/news/home/20170223006455/en/
[ Back To TMCnet.com's Homepage ]
|